期刊文献+

中国居民2004~2016年肝癌死亡趋势分析 被引量:19

Analysis of liver cancer mortality trend among Chinese residents from 2004 to 2016
在线阅读 下载PDF
导出
摘要 目的:分析2004~2016年中国居民肝癌死亡状况及变化趋势。方法:汇总2004~2016年中国居民肝癌死亡数据,分析肝癌粗死亡率及年龄标化死亡率特征,选取标化死亡率拟合Joinpoint回归模型分析肝癌死亡趋势。结果:2004~2016年中国居民肝癌标化死亡率总体呈下降趋势,平均年度变化百分比(AAPC)为-2.593%;男性标化死亡率高于女性且下降速度较慢(AAPC=-2.454%);农村居民标化死亡率高于城市,但下降速度较快(AAPC=-2.943%),城乡差距逐渐缩小;不同年龄组肝癌死亡状况变化存在差异,青年人群肝癌标化死亡率呈下降趋势,50~55岁中年人群死亡状况呈恶化趋势,85岁以上高龄老年人群死亡状况改善不明显。结论:中国居民肝癌死亡状况总体好转,但存在性别和城乡差异,个别年龄组的死亡趋势不容乐观。 Aim:To analyze the mortality rates and trend of liver cancer in Chinese residents from 2004 to 2016.Methods:The data of liver cancer mortality rates in Chinese residents from 2004 to 2016 were collected,and the characteristics of crude liver cancer mortality rates and age-standardized mortality rates were analyzed.The standardized mortality rate fitting Joinpoint regression model was used to analyze the mortality trend of liver cancer.Results:The standardized mortality rates of liver cancer in Chinese residents showed a downward trend from 2004 to 2016,the average annual percent change(AAPC)was-2.593%.The standardized mortality rate for males was higher than that for females and declined slowly(AAPC=-2.454%).The standardized mortality rate of rural residents was higher than that of urban residents,and declined relatively fast(AAPC=-2.943%),and the gap between urban and rural areas was gradually narrowing.There were differences in the changes of liver cancer mortality rate among different age groups.The standardized mortality rate of liver cancer in young people showed a significant downward trend,the mortality situation of people aged 50 to 55 years was deteriorating,and the improvement of mortality situation of people over 85 years old was not obvious.Conclusions:The mortality situation of liver cancer in Chinese residents has generally improved,but gender and urban-rural differences still exist,and the mortality trend of several age groups is not optimistic.
作者 贺君剑 魏长慧 李众 曾益 唐齐鑫 李芳伟 石妍妍 温书景 郝义彬 孙长青 HE Junjian;WEI Changhui;LI Zhong;ZENG Yi;TANG Qixin;LI Fangwei;SHI Yanyan;WEN Shujing;HAO Yibin;SUN Changqing(Department of Social Medicine and Health Service Management,College of Public Health,Zhengzhou University,Zhengzhou 450001;Department of Radiotherapy,Henan Cancer Hospital,Zhengzhou 450008;Department of Internal Medicine,Luoyang Petrochemical Hospital,Luoyang,Henan 471012)
出处 《郑州大学学报(医学版)》 CAS 北大核心 2020年第1期119-122,共4页 Journal of Zhengzhou University(Medical Sciences)
基金 河南省科技攻关重点项目(192102310191)
关键词 肝癌 死亡率 趋势分析 中国 liver cancer mortality rate trend analysis China
  • 相关文献

参考文献7

二级参考文献64

  • 1郑树森,梁廷波,吴应盛.老年人原发性肝癌的诊治[J].中华老年多器官疾病杂志,2002,1(1):34-35. 被引量:6
  • 2田银生,张清华,朱宇.住院肝癌患者112例心理特征及相关因素调查[J].中国临床康复,2006,10(10):16-18. 被引量:20
  • 3Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics, 2002 [J]. CA Cancer J Clin, 2005, 55(2): 74-108.
  • 4Tateishi Rj Shiina S, Teratani T, et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases[J]. Cancer, 2005, 103(6): 1201-1209.
  • 5Bruix J, Sherman M. Management of hepatocellular carcinoma: an update[J]. J Hepatol, 2010, 53(3): 1020-1022.
  • 6Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma[J]. J Hepatol, 2012, 57(4): 794-802.
  • 7Pompili M, Saviano A, de Matthaeis N, et al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <_3cm. Results of a multicenter Italian survey[J].J Hepatol, 2013, 59(1): 89-97.
  • 8Huang J Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria[J]. Ann Surg, 2010, 252(6): 903-912.
  • 9Kao WYj Chiou YY, Hung HH, et al. Risk factors for long-term prognosis in hepatocellular carcinoma after radiofrequency ablation therapy: the clinical implication of aspartate aminotransferase-platelet ratio index[J]. Eur J Gastroenterol Hepatol, 2011, 23(6): 528-536.
  • 10Oeda S, Mizuta T, Isoda H, et al. Survival advantage of radiofrequency ablation for hepatocellular carcinoma: comparison with ethanol injection[J]. Hepatogastroenterology, 2013, 60(126): 1399-1404.

共引文献733

同被引文献251

引证文献19

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部